MitoRx Publishes Study on AP39’s Effectiveness in Reducing Obesity
MitoRx Therapeutics has published a study in Pharmacological Research demonstrating that its mitochondrial-targeted sulfide-donor compound, AP39, significantly reduces weight gain and fatty liver. This study is the first to explore … Read more